Oragenics (OGEN) Free Cash Flow (2010 - 2026)
Oragenics' (OGEN) quarterly Free Cash Flow came in at -$2.2 million in Q1 2026, down 4.19% YoY from -$2.3 million in Q1 2025, and up 21.41% on a QoQ basis from -$2.8 million in Q4 2025.
Oragenics (OGEN) Free Cash Flow (2010 - 2026) Analysis & Trends
Oragenics (OGEN) has 17 years of Free Cash Flow data on file, last reported at -$2.2 million in Q1 2026.
- Quarterly Free Cash Flow fell 4.19% year-over-year to -$2.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$9.3 million (down 21.49% YoY) and the FY2025 annual result came in at -$9.2 million, down 7.01% from the prior year.
- Free Cash Flow improved to -$2.2 million in Q1 2026, from -$2.8 million in the prior quarter.
- In the past five years, Free Cash Flow ranged from a high of -$1.1 million in Q4 2023 to a low of -$5.7 million in Q1 2022.
- A 5-year average of -$2.5 million and a median of -$2.2 million in 2026 frame the typical range for Free Cash Flow.
- Annual changes were most pronounced in 2023 — Free Cash Flow soared 63.16% — and 2024, when it sank 83.06%.
- Tracing OGEN's Free Cash Flow over 5 years: stood at -$2.4 million in 2022, then soared by 54.74% to -$1.1 million in 2023, then slumped by 83.06% to -$2.0 million in 2024, then slumped by 38.73% to -$2.8 million in 2025, then rose by 21.41% to -$2.2 million in 2026.
- The last three Free Cash Flow figures came in at -$2.2 million (Q1 2026), -$2.8 million (Q4 2025), and -$3.0 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Free Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 1.01 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 572.80 Mn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | - |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | -563.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 437.80 Mn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 292.04 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | -95.09 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 477.44 Mn |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 433.84 Mn |
| 10 | Oragenics | 2.38 Mn | 2.38 Mn | - | -2.20 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -2.20 Mn |
| Jun 30, 2026 | -2.20 Mn |
| Mar 31, 2026 | -2.20 Mn |
| Mar 31, 2026 | -2.20 Mn |
| Dec 31, 2025 | -2.80 Mn |
| Dec 31, 2025 | -2.80 Mn |
| Sep 30, 2025 | -3.00 Mn |
| Sep 30, 2025 | -3.00 Mn |
| Jun 30, 2025 | -1.29 Mn |
| Jun 30, 2025 | -1.29 Mn |
| Mar 31, 2025 | -2.11 Mn |
| Mar 31, 2025 | -2.11 Mn |
| Dec 31, 2024 | -2.02 Mn |
| Dec 31, 2024 | -2.02 Mn |
| Sep 30, 2024 | -1.97 Mn |
| Sep 30, 2024 | -1.97 Mn |
| Jun 30, 2024 | -1.54 Mn |
| Jun 30, 2024 | -1.54 Mn |
| Mar 31, 2024 | -3.06 Mn |
| Mar 31, 2024 | -3.06 Mn |